Overview
Suxin Li practices practicing medicine in Zhengzhou, China.
Li is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Budd-Chiari Syndrome, Hypersplenism, Mesenteric Venous Thrombosis, and Liver Cancer.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Suxin Li
Is Suxin Li a top-rated expert for Budd-Chiari Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Suxin Li is classified as an Advanced expert for Budd-Chiari Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Suxin Li participate in research or clinical trials?
Yes. Suxin Li has published 9 articles and abstracts on conditions like Budd-Chiari Syndrome. You can view a list of Suxin Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Budd-Chiari Syndrome
- Experienced
- HypersplenismLi isExperienced. Learn about Hypersplenism.
- Liver CancerLi isExperienced. Learn about Liver Cancer.
- Mesenteric Venous Thrombosis
- Portal HypertensionLi isExperienced. Learn about Portal Hypertension.